These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2669102)

  • 1. Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries.
    Munson RS; Kabeer MH; Lenoir AA; Granoff DM
    Rev Infect Dis; 1989; 11 Suppl 3():S588-97. PubMed ID: 2669102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus influenzae disease and immunization in developing countries.
    Funkhouser A; Steinhoff MC; Ward J
    Rev Infect Dis; 1991; 13 Suppl 6():S542-54. PubMed ID: 1862284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
    Iwarson S
    Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for prevention of invasive Haemophilus influenzae type b infections in Geneva, Switzerland.
    Gervaix A; Suter S
    Vaccine; 1993; 11 Suppl 1():S34-7. PubMed ID: 8447172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of Haemophilus influenzae type b infections among children in Denmark in 1985 and 1986.
    Kristensen K; Kaaber K; Rønne T; Larsen SO; Henrichsen J
    Acta Paediatr Scand; 1990; 79(6-7):587-92. PubMed ID: 2386050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia.
    Claesson BA
    Vaccine; 1993; 11 Suppl 1():S30-3. PubMed ID: 8447171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
    Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
    JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.
    Martin M; Casellas JM; Madhi SA; Urquhart TJ; Delport SD; Ferrero F; Chamany S; Dayan GH; Rose CE; Levine OS; Klugman KP; Feikin DR
    Pediatr Infect Dis J; 2004 Sep; 23(9):842-7. PubMed ID: 15361724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leads from the MMWR. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    JAMA; 1985 May; 253(18):2630, 2636-7. PubMed ID: 3872947
    [No Abstract]   [Full Text] [Related]  

  • 13. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.
    Singleton R; Hammitt L; Hennessy T; Bulkow L; DeByle C; Parkinson A; Cottle TE; Peters H; Butler JC
    Pediatrics; 2006 Aug; 118(2):e421-9. PubMed ID: 16882783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
    Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilus influenzae type b polysaccharide vaccine.
    Cates KL
    Pediatr Ann; 1986 Jun; 15(6):461-3, 467-8. PubMed ID: 3523406
    [No Abstract]   [Full Text] [Related]  

  • 17. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
    Watt JP; Wolfson LJ; O'Brien KL; Henkle E; Deloria-Knoll M; McCall N; Lee E; Levine OS; Hajjeh R; Mulholland K; Cherian T;
    Lancet; 2009 Sep; 374(9693):903-11. PubMed ID: 19748399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H influenzae in the post-vaccination era.
    Peltola H
    Lancet; 1993 Apr; 341(8849):864-5. PubMed ID: 8096567
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of Haemophilus influenzae type b infections in day care: a public health perspective.
    Fleming DW; Cochi SL; Hull HF; Helgerson SD; Cundiff DR; Broome CV
    Rev Infect Dis; 1986; 8(4):568-72. PubMed ID: 3529312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
    Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
    Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.